
    
      A Single-centre, Randomized, Open-label, Two-period, Cross-over, Bioequivalence Study of the
      Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration of the
      Individual Components in two cohorts of Healthy Chinese Subjects under Fed Conditions
    
  